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Mitochondria are believed to derive from engulfed α-proteobacteria, 
so it is hardly a surprise that they contain their own genome. What 
is surprising, though, is that they continue to maintain a tiny fraction 
of their original genome after 1.3 billion years of symbiosis with their 
eukaryotic host, when the vast majority of the mitochondrial genome 
has been either lost completely (no longer needed due to change of 
lifestyle), or transferred to the host nucleus. While it takes around 
3,000 genes to make a mitochondrion in a human cell, the human 
mitochondrial genome contains only 13 protein-coding genes, among 
which 5 (ND1, ND4, ND5, CYTB and COX1) are universally retained 
in all organisms (except in organisms for whom aerobic metabolism or 
part of the electron transport chain is no longer necessary) [1,2]. The 
transfer of mitochondrial DNA (mtDNA) to the nuclear genome is an 
ongoing process and is still happening today [3]. A survey of human 
nuclear DNA sequences identified the existence of large mtDNA 
fragments in many chromosomes [4]. Under certain circumstances 
that compromise mitochondrial integrity, such as during digestion by 
lysosomes or when undergoing fusion, pieces of mtDNA can escape 
from mitochondria and move to the nucleus. Mitochondrial DNA 
can also be transferred to the nucleus through illicit use of the nucleic 
acid transport system and through occasional fusion of mitochondrial 
and nuclear membranes. When ending up in the nucleus, mtDNA can 
integrate into the host genome through a number of mechanisms, such 
as double-strand-break repair. When a mitochondrial gene integrates 
into the nuclear genome at a spot containing intact regulatory elements 
as well as a mitochondrial targeting sequence, a functional transfer is 
accomplished. 
The horizontal DNA transfer between mitochondria and the 
nucleus is not a one-way street; it can happen both ways. Just like 
their proteobacterial ancestors, mitochondria can take up DNA from 
their environment [5]. The net one-way flow of genetic material from 
mitochondria to the nucleus and the consequent dramatic reduction 
of mitochondrial genome over time, however, indicate that evolution 
favors the migration of genetic information from the cellular “power 
plant” to the nucleus, the centralized genetic blueprint storage site 
in a cell. To answer the question of why evolution favors the transfer 
of genetic information from mitochondria to the nucleus, or more 
importantly, what is the evolutionary advantage offered by this DNA 
migration, we have to examine the environment in which mtDNA 
resides. As the powerhouse of the cell, mitochondria are also the major 
producer of cellular pollutants, i.e., reactive oxygen species, such as 
superoxide and hydrogen peroxide. Seated in the midst of these highly 
reactive molecules, mtDNA is constantly bombarded and therefore has 
a mutation rate that is much higher than the nuclear DNA. To make the 
situation worse, the DNA repair system in this organelle is more limited 
than it is in the nucleus. Clearly, this organelle is not an ideal location 
for storing DNA molecules. 
The detrimental effects of storing key metabolism-related genes 
in the mitochondria genome become all the more apparent in the 
process of aging and mitochondrial diseases. The accumulation of 
mtDNA mutations is a characteristic of the aging process. Although 
it is still controversial as to whether it is a cause or an effect of aging, 
it is clear that mitochondrial dysfunction due to mtDNA mutations 
leads to energy deficits in cells, which increases their vulnerability 
to the various stressors that ultimately result in cell senescence. 
Mitochondrial DNA ‘mutator’ mice, which were genetically altered to 
elevate the rate of mtDNA mutation, show multiple signs of premature 
aging [6,7]. In the central nervous system, mitochondrial dysfunction 
due to accumulation of mutant mtDNA in vulnerable brain regions is 
a salient feature of a number of neurodegenerative diseases, including 
Alzheimer’s disease and Parkinson’s disease [8]. In heart and skeletal 
muscle, accumulated mtDNA mutations lead to energy generation 
deficiencies and to cardiovascular diseases and myopathies. Besides 
these well known mitochondrial diseases, inherited or spontaneous 
mtDNA mutations can lead to a growing list of mitochondrial diseases 
that lead to visual/hearing difficulties, liver dysfunction, respiratory 
complications, developmental delay, diabetes, gastro-intestinal 
disorders, lactic acidosis and vulnerability to infections [2]. 
If mitochondria are not the ideal location for storing genetic 
information and accumulation of mtDNA mutations is detrimental 
to our survival, why do a small number of genes remain in the 
mitochondria? Several hypotheses have been proposed [9]. The first 
is the hydrophobicity hypothesis, which postulates that the high 
hydrophobicity of proteins coded by the remaining mitochondrial genes 
creates a barrier for their relocation to the nucleus. Some mtDNA coded 
proteins, such as NADH dehydrogenase subunit 4 (ND4) of complex 
I and cytochrome b (CYTB) of complex III, are highly hydrophobic 
and have multiple transmembrane domains. If their coding genes 
are transferred to the nucleus, importing them to the mitochondria, 
while still maintaining functional folding and spatial structure, would 
not be a trivial task. This hydrophobicity hypothesis can explain why 
some genes are still retained in the mitochondria. However, not all 
proteins coded by mtDNA are hydrophobic. The second hypothesis 
proposes that retaining certain genes inside the mitochondria is for 
the effective control of their expression and the efficient incorporation 
*Corresponding author: Xinkun Wang, Higuchi Biosciences Center, The 
University of Kansas, 2099 Constant Avenue, Lawrence, KS 66047, USA, Tel: +1 
(785) 864-4589; E-mail: xwang@ku.edu
Received March 05, 2012; Accepted March 07, 2012; Published March 09, 2012
Citation: Wang X (2012) Integrate the Mitochondrial Genome into the Nuclear 
Genome. Bioenerg Open Access 1:e103. doi:10.4172/ .1000e103
Copyright: © 2012 Wang X. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original author and 
source are credited.
Integrate the Mitochondrial Genome into the Nuclear Genome
Xinkun Wang*
Higuchi Biosciences Center, University of Kansas, USA
Abstract
The mitochondrion is not an ideal location for storing genetic information. Evolution has relocated most of the 
mitochondrial genome to the nucleus. Transferring all remaining mitochondrial DNA to the nucleus might be an effective 
approach to cure mitochondrial diseases and slow down aging. 
Wang, Bioenerg Open Access 2012, 1:2
http://dx.doi.org/10.4172/2167-7662.1000e103
Volume 1 • Issue 2 • 1000e103
Page 2 of 3
Bioenerg Open Access
ISSN: 2167-7662 BEG an open access journal 
of their protein products into proper protein complexes in the inner 
membrane. If the same genes are transferred to the nucleus and their 
mRNA translated in the cytoplasm, the coded polypeptides might be 
transported into other intracellular membranes (such as endothelial 
reticulum) and induce local oxidative damage [10,11]. The third 
proposed mechanism for thwarting mtDNA transfer to the nuclear 
genome is the use of alternative genetic codons in the mitochondria of 
some organisms such as animals (including humans). 
To counter the use of alternative codons in mtDNA, re-coding 
mitochondrial genes using the universal genetic code and then 
transferring them out of the mitochondria and into the nucleus is 
easily achieved in this day and age. This technique, called allotopic 
expression, was first employed to transfer the mitochondrial ATP8 
gene to the nucleus in yeast cells in 1986 [12]. In human cells this 
was first accomplished in 2002, when the mitochondrial ATP6 gene, 
with the addition of a mitochondrial targeting sequence, was re-
coded and introduced into the nuclear genome [13]. In this endeavor, 
the recombinant gene was translated in the cytoplasm and the 
resultant polypeptide was transported back into and processed within 
mitochondria where it became an integral part of complex V. So far 
a number of mitochondrial genes, including ATP6 [13-17], ATP8 
[12,18], ND1 [19] and ND4 [16,19-23], have been integrated into 
the nuclear genome. The protein products of these allotopic genes 
can function within mitochondria. As a result, cellular dysfunction 
caused by corresponding mutant versions of these genes located in 
the mitochondrial genome can be complemented. Therefore, allotopic 
expression could offer an effective strategy for mitochondrial gene 
therapy to combat mitochondrial diseases caused by mtDNA mutation, 
such as Leber’s Hereditary Optic Neuropathy (LHON), one of the 
most prevalent mitochondrial diseases. In rodent models of LHON, 
intraocular injection and in vivo electroporation of re-coded ND4 
gene for allotopic expression rescued mitochondrial dysfunction in the 
affected retinal neurons and prevented impairment of visual function 
[21,23]. Since both in vitro studies and in vivo animal experiments 
have shown the promise and benefit of using gene transfer from the 
mitochondria to the nucleus in the treatment of LHON, human clinical 
trials using this approach of treatment are currently under way [24]. 
Besides curing mitochondrial diseases such as LHON, moving mtDNA 
out of the organelle to the nucleus is expected to promote overall health, 
reduce incidence of diseases (not just mitochondriopathies) and slow 
down aging [25].
Despite the successes, there are a number of road blocks that need 
to be overcome if transfer of all 13 remaining human mtDNA structural 
genes to the nucleus is to occur. First, the high hydrophobicity of some 
of the mtDNA-coded proteins remains a barrier [26]. Although the 
import of the allotopically expressed genes into the mitochondria shows 
that the hydrophobicity barrier can be overcome, most of these genes 
were not re-coded for reduction of hydrophobicity, so the efficiency 
of their import is still low. To further overcome this barrier, their 
hydrophobicity needs be reduced by altering amino acid composition in 
their transmembrane domain regions. It has been shown that alteration 
of a couple of key amino acids is sufficient sometimes [27]. To deal with 
extreme protein hydrophobicity, other approaches, such as the use of 
inteins [28], are proposed. Second, the import and incorporation of 
allotopically expressed proteins into the mitochondria are still tricky, 
because allotopically expressed inner membrane proteins are sometimes 
mistakenly placed on the outer membrane [29], or they may fail to 
be incorporated into appropriate mitochondrial protein complexes 
[29,30]. More understanding with regard to the import and assembly of 
nuclear-genome-encoded mitochondrial proteins is still needed. 
In terms of transferring mitochondrial genes to the nucleus, 
Chlamydomonas reinhardtii, a green alga, is a pioneer, with only 7 
metabolically related genes retained in its mitochondrial genome 
[31]. A number of mitochondrial proteins that are considered too 
hydrophobic to transfer to the nuclear genome and still coded by the 
mitochondrial genome in all other species (including humans), have 
been transferred to the nucleus in C. reinhardtii. The smaller number 
of genes in the C. reinhardtii mitochondrial genome and the allotopic 
expression of the various mitochondrial proteins described above, 
make us reach the hypothesis that there is a hierarchical order for the 
transfer of mitochondrial genes to the nuclear genome and that the 
most hydrophobic ones are simply the last to be moved out. Without 
intervention, the transfer of this last batch of genes might take tens of 
millions of years. With human ingenuity, the transfer may be completed 
within a much shorter time frame. With a clean mitochondrion and the 
beauty of one cell – one genome, we may find that many of the health 
problems we face today would vanish along with the mitochondrial 
genome. Or, we may find other, previously unappreciated reasons that 
have prevented the transfer of the last few mitochondrial genes to the 
nucleus. 
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